WealthOne’s Thermo Fisher Scientific TMO Stock Holding History

WealthOne’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-120	Closed	-$27K	–	497
2018 Q4	$27K	Buy	+120	New	+$28.2K	0.02%	243

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WealthOne's TMO Position: Q1 2019 in Review

WealthOne sold out of Thermo Fisher Scientific (TMO) in Q1 2019, closing a stake of 120 shares — an estimated $27K sold.

WealthOne first reported a position in TMO in Q4 2018 and held it in 1 quarter. The position peaked at $27K in Q4 2018. 1,523 funds tracked by Wall St. Rank hold TMO as of Q1 2019.

WealthOne reported no remaining Thermo Fisher Scientific position as of Q1 2019 after selling out during the quarter.
WealthOne sold 120 Thermo Fisher Scientific shares in Q1 2019, an estimated $27K.
WealthOne first reported a position in Thermo Fisher Scientific in Q4 2018 and held it in 1 quarter.
WealthOne's Thermo Fisher Scientific position peaked at $27K in Q4 2018.
1,523 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2019.

Based on WealthOne's 13F filing for Q1 2019, filed 16 May 2019.